EKSO Q3 2022 Earnings — Ekso Bionics Holdings, Inc. Revenue & Financial Results | Market Cap Arena

EKSOEkso Bionics Holdings, Inc.

$29M

Q3 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$3M+9.2% YoY

Gross Profit

$2M50.6% margin

Operating Income

-$4M-109.8% margin

Net Income

-$4M-129.3% margin

EPS (Diluted)

$-0.38

QoQ Revenue Growth

-3.9%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$581,000

Balance Sheet

Total Assets

$39M

Total Liabilities

$11M

Stockholders' Equity

$29M

Cash & Equivalents

$29M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	+9.2%
Gross Profit	$2M	$2M	-6.7%
Operating Income	-$4M	-$3M	-31.0%
Net Income	-$4M	-$2M	-119.8%

Revenue Segments

EksoHealth

$3M97%

EksoWorks

$105,0003%

Geographic Segments

Americas

$2M23%

UNITED STATES

$1M22%

EMEA

$1M16%

Asia Pacific

$723,00011%

INDONESIA

$668,00010%

ROMANIA

$449,0007%

EMEA, Other

$372,0006%

GERMANY

$237,0004%

Americas, Other

$73,0001%

APAC, Other

$55,0001%